EEFT Short Sellers Press Ahead of Q3 Print
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
Euronet Worldwide reports third-quarter results today, with short sellers at their most aggressive in over a year and the stock trailing its payment-sector peers by a wide margin.
Short interest has climbed to 13.5% of the free float, up 16.6% over the past month and sitting at the highest level recorded in the dataset. The official FINRA fortnightly figure puts shares short at 5.64 million, with days to cover at 7.5. That is a meaningful build: in mid-September, the short position was closer to 4.84 million shares. The borrow market remains orderly, with availability at 347%, meaning there are roughly 3.5 shares available to lend for every one already borrowed, and cost to borrow at just 0.57%. The lending pool is not under stress; short sellers have been adding positions without encountering friction.
The stock has not helped the bulls. At $63.95, EEFT is down 2.5% over the past month and off 1.4% on the week, while close payment-sector peers diverged: FIS gained 4.2% and FISV added 4.9% over the same five days, with WU up 2.8%. The ORTEX short score has held between 66.8 and 67.6 for two weeks, a range that places the stock in the bottom 7th percentile of its universe on short positioning.
The bear case rests on a specific macro shift. FX moved from a tailwind of roughly 120 basis points in the second quarter to an expected headwind of 150 to 175 basis points in the back half. Euronet's largest segment, Money Transfer, faces a year-on-year revenue decline driven by tighter US immigration enforcement and softer remittance volumes. Debt has grown to $2.6 billion against $2.1 billion in cash and ATM cash, and a roughly $700 million Eurobond maturing in May is expected to be refinanced at a materially higher rate. Stephens reinstated coverage on October 16 with an Equal-Weight rating and a $71 target, close to the current price, while Wolfe Research holds an Underperform with a $70 target. The consensus mean sits at $81.86 across seven analysts, with Needham at $90 and DA Davidson at $102, but those optimistic targets reflect a bull case premised on Digital Accelerators reaching 30% of revenue by 2028 and adjusted EPS compounding at 10% to 15% annually. On trailing earnings, the stock trades at a P/E of 5.5x and an EV/EBITDA of 3.6x, multiples that factor scores place in the 84th and 86th percentiles for earnings yield and EV/EBIT value. The cheapness is not in dispute; the disagreement is whether the earnings trajectory justifies confidence in those multiples.
Options positioning has eased slightly rather than tightened into today's release. The put/call ratio at 0.92 is fractionally below its 20-day average of 0.93, making it one of the less defensive readings of the past month. That sits in contrast with the short-interest build, where the conviction has been expressed through the equity lending market rather than through options hedges.
Retail attention has spiked. The ORTEX alt data layer shows Wikipedia page views running at a z-score of 2.3, the highest in recent months, suggesting the print has attracted more attention beyond the institutional community than is typical for this name.
Today's result will test whether the company's Q3 numbers show the FX and remittance headwinds biting as sharply as bears have positioned for, or whether management's digital-segment growth and buyback cadence provide enough offset to challenge a short position that is now at record levels.
Stocks in this article
See the live data behind this article on ORTEX.
Open EEFT on ORTEX →How this article was generated
- Generated
- 27 Oct 2026, 04:22
- Data as of
- 27 Oct 2026, 04:02
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt DataIndex Rebalance
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.